This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
If You Invested $1000 in Salesforce.com a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Stock Market News for Dec 5, 2023
by Zacks Equity Research
Wall Street ended lower on Monday, with investors taking a pause after major indexes recorded five straight weeks of gains as they awaited employment data.
Here is What to Know Beyond Why Salesforce Inc. (CRM) is a Trending Stock
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
5 Stocks That Powered S&P 500 ETF This Year
by Sweta Killa
As the rally has been broad-based, we have highlighted five stocks in ETFs from different industries that have doubled or near to double so far this year.
The Zacks Analyst Blog Highlights Meta Platforms, JPMorgan Chase, Salesforce, Medtronic and PNC Financial
by Zacks Equity Research
Meta Platforms, JPMorgan Chase, Salesforce, Medtronic and PNC Financial are included in this Analyst Blog.
Top Research Reports for Meta Platforms, JPMorgan Chase & Salesforce
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), JPMorgan Chase & Co. (JPM) and Salesforce, Inc. (CRM).
Pre-Markets in the Red to Start December
by Zacks Equity Research
Pre-Markets in the Red to Start December
Friday Pre-Market Quiets, Indices Slightly Lower
by Mark Vickery
The past month of trading has been extraordinary, with the S&P +7.4%, both the Dow and Russell +7.9% and the Nasdaq +8.1%.
Stock Market News for Dec 1, 2023
by Zacks Equity Research
U.S. stocks ended mostly higher on Thursday, with the Dow recording its highest close since January 2022, while the Nasdaq and S&P 500 registered their best monthly gains since July 2022 as fresh data showed inflation cooled further in October.
Big Day on the Dow, +520 Points; ULTA Beats & Raises
by Mark Vickery
The Dow cleaned up this session: +520 points, +1.47%, led by Salesforce (CRM) coming off its impressive Q3 earnings report yesterday.
Salesforce (CRM) Soars 9% on Q3 Earnings Beat, Raises Guidance
by Zacks Equity Research
Salesforce's (CRM) Q3 earnings reflect the benefits of the resilient demand for its cloud and software offerings in a challenging macroeconomic environment and cost-restructuring initiatives.
Markets Mixed as November Trading Nearly Over; CRM, SNOW Beat; PVH Mixed
by Mark Vickery
We're now one day from closing out the month of November, and gains to this point have been excellent.
Salesforce.com (CRM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Salesforce.com (CRM) give insight into how the company performed in the quarter ended October 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Rapid Cloud Adoption to Drive Salesforce's (CRM) Q3 Earnings
by Zacks Equity Research
Salesforce's (CRM) Q3 revenues and earnings are likely to have benefited from the cloud migration and digital transformation initiatives adopted by enterprises despite ongoing macroeconomic headwinds.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Salesforce (CRM) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
While the growing adoption of generative AI-enabled solutions and the continued cloud migration are likely to have aided Salesforce's (CRM) top line in Q3, cost-cutting initiatives are anticipated to have boosted the bottom line.
The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce
by Zacks Equity Research
Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce are included in this Analyst Blog.
Top Stock Reports for Eli Lilly, Accenture & The TJX Companies
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Accenture plc (ACN) and The TJX Companies, Inc. (TJX).
Exploring Analyst Estimates for Salesforce.com (CRM) Q3 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Salesforce.com (CRM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2023.
Is Trending Stock Salesforce Inc. (CRM) a Buy Now?
by Zacks Equity Research
Salesforce.com (CRM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Analyst Blog Highlights Intel, The Procter & Gamble, 3M, salesforce.com and Microsoft
by Zacks Equity Research
Intel, The Procter & Gamble, 3M, salesforce.com and Microsoft are part of the Zacks top Analyst Blog .
C3.ai (AI) Expands Portfolio With AWS Marketplace Edition
by Zacks Equity Research
C3.ai (AI) launches C3 Generative AI: AWS Marketplace Edition to help users be more productive in the future.
Zacks Industry Outlook Highlights Adobe, Salesforce and Cadence Design Systems
by Zacks Equity Research
Adobe, Salesforce and Cadence Design Systems are part of the Zacks Industry Outlook article.
5 Top Blue-Chip Stocks to Gain From Recent Market Rally
by Nalak Das
Defying a tepid Dow, we have narrowed our search to five blue-chip (components of Dow) stocks are: MSFT, MMM, CRM, INTC, PG.
Analog Devices (ADI) Q4 Earnings Meet, Revenues Fall Y/Y
by Zacks Equity Research
Analog Devices' (ADI) results for the fiscal fourth quarter reflect weakness across the industrial, communications and consumer markets.